Agilent Technologies Collaborating with Weill Cornell Medical College to Advance Research in ALS
August 26, 2015
SANTA CLARA, Calif. – Agilent Technologies Inc. (NYSE: A) today announced it is collaborating with Dr. Steven Gross, a faculty member in the Department of Pharmacology at Weill Cornell Medical College, in New York, N.Y., to advance research in amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease. Agilent will provide the latest mass spectrometry [...]
August 26, 2015
SOUTH EASTON, Mass -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced it has entered into a two-year collaboration with the Institute of Bioinformatics ("IOB") in Bangalore, India. The [...]
Luminex Corporation Submits 510(k) Application for the NxTAG® Respiratory Pathogen Panel
August 26, 2015
AUSTIN, Texas -- Luminex Corporation (NASDAQ: LMNX) today announced that it has submitted a 510(k) application to the FDA for the company's NxTAG® Respiratory Pathogen Panel. This panel is the only respiratory assay that will easily enable laboratories to simultaneously detect 21 respiratory pathogens in a single closed tube system in a format that scales [...]
Allele Biotech Takes Major Step into Nano Antibody Leadership Position
August 26, 2015
SAN DIEGO -- Allele Biotechnology & Pharmaceuticals Inc., a San Diego based life sciences company with a focus on novel technology development, releases the first group of a brand new class of antibodies against crucial biological targets to the research market. This week, Allele launches nano-antibodies isolated from llamas against human bFGF, P16, VEGF, and [...]
ALPCO Releases New STELLUX® Chemiluminescent Adiponectin ELISAs
August 25, 2015
Salem, NH -- ALPCO recently announced the launch of its new STELLUX® Chemiluminescent Total Adiponectin and HMW Adiponectin ELISAs. These highly characterized assays can measure total and HMW adiponectin forms respectively using only 5 µL of human serum or plasma. These are the only commercially available Adiponectin ELISAs that demonstrate specificity to the different forms [...]
SYGNIS signs non-exclusive distribution agreement for Australia with GeneWorks Pty Ltd
August 25, 2015
Madrid, Spain and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that it has signed a non- exclusive distribution agreement for the commercialization of SYGNIS’ proprietary product portfolio in Australia with GeneWorks Pty Ltd. Under the terms of the agreement, SYGNIS has granted GeneWorks the rights to promote, market and [...]
BD to Acquire Cellular Research to Develop a Leading Genomics Platform for Single Cell Analysis
August 25, 2015
FRANKLIN LAKES, N.J. -- BD Life Sciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), today announced it has completed the acquisition of Cellular Research, Inc. BD is a global leader in characterizing and isolating single cells for analysis, with more than 30 years of experience in developing [...]
August 25, 2015
WILMINGTON, Mass. -- Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 22 of its QS-B220 desktop trace detectors to international airports in Austria, continuing its sales success in the European aviation market. With this contract [...]
August 25, 2015
Bielefeld: LaVision BioTec, developers of advanced microscopy solutions for the life sciences, report on the work of Ali Ertürk, a Group Leader at the Institute for Stroke and Dementia Research (part of the Klinikum der Universität München) at the Ludwig Maximilians University in Munich, Germany. Dr Ali Ertürk has been using light sheet and 2-photon [...]
Epigenetic Proteins for Drug Discovery
August 25, 2015
St Charles, MO -- Eurofins Pharma Discovery Services announces the launch of its portfolio of epigenetic proteins for direct sale to epigenetic researchers and drug discovery scientists. These proteins are used in industry-leading epigenetic screening and profiling services also available through Eurofins Pharma Discovery Services, since 2012. Epigenetic analysis is an increasingly important area of [...]

